Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

Franklin Strategic Biotechnology: (MF: FBDIX)

(MF) As of Jul 18, 2014 06:05 PM ET

 Add to portfolio

$136.36 USD

+3.84 (2.90%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

General Information as of Jun 30, 2014

% Yield 0.00
% SEC Yield NA
% YTD Return (as of Jun 30, 2014) 9.85
Objective* Equity - Sector Health
Peer* HL MG

*Key

Zacks Premium Research for FBDIX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Rank Change Trend Buy 2
MF Research Report

( = Change in last 30 days)

Zacks Mutual Fund #1 Ranked Funds

View the Zacks Mutual Fund Rank Guide

Portfolio Statistics

%Unrealized Gain YTD 26.06
Net Assets (Mil $) 6/30/2014 986.35
%Turnover 6/30/2014 33.64

Allocation

% of Portfolio
Large Growth 29.85
Large Value 0.00
Small Growth 7.92
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 26.40
Foreign Bond 0.00
High Yield Bond 0.00

Sector / Country Weightings

As of 6/30/2014 % of Portfolio
Health 55.14
Services 22.35
Other 10.16
Industrial Cyclical 8.76
Technology 2.82
Retail Trade 0.58
Non-Durable 0.19

Portfolio Holdings

Top Equity Holdings
(As of 4/30/2014)
% of Portfolio Value (Mil$)
GILEAD SCIENCES INC 11.00 141.79
BIOGEN IDEC INC 7.67 98.90
AMGEN INC 5.26 67.83
REGENERON PHARMACEUTICALS 5.12 66.06
CELGENE CORP 5.11 65.88
MEDIVATION INC 4.42 56.93
ALEXION PHARMACEUTICALS I 3.11 40.14
INCYTE PHARMACEUTICALS IN 2.93 37.83
ILLUMINA INC 2.82 36.39

Stock Holding % of Net Assets

As Of 4/30/2014
Total Issues 113
Avg. P/E 43.72
Avg. P/Book 5.70
Avg. EPS Growth 15.08
Avg. Market Value (Mil $) 35,262

Risk

3 Year 5 Year 10 Year
Beta 0.98 0.95 0.80
Alpha 15.51 9.21 7.05
R Squared 0.30 0.40 0.37
Std. Dev. 21.79 20.15 19.53
Sharpe 1.60 1.46 2.00